1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. NeuBase Therapeutics Inc (NBSE)
  7. Quote

NBSE NBSE

NeuBase Therapeutics Stock Price

2.69
-0.20 (-6.92%)
Upgrade to Real-Time
Afterhours (Closed)
2.69
Volume 122,290
Bid Price 2.22
Ask Price 3.21
News -
Day High 2.88

Low
2.66

52 Week Range

High
12.89

Day Low 2.68
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
NeuBase Therapeutics Inc NBSE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.20 -6.92% 2.69 00:00:06
Open Price Low Price High Price Close Price Prev Close
2.88 2.68 2.88 2.69 2.89
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,145 122,290 $ 2.74 $ 335,407 - 2.66 - 12.89
Last Trade Time Type Quantity Stock Price Currency
16:12:57 formt 300 $ 2.68 USD

Period:

Draw Mode:

NeuBase Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 88.01M 32.72M 28.02M $ - $ - -0.90 -3.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 177.54k 4.80%

more financials information »

NeuBase Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NBSE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.203.242.662.93177,122-0.51-15.94%
1 Month3.683.752.663.27160,561-0.99-26.9%
3 Months3.694.402.663.65154,840-1.00-27.1%
6 Months5.135.512.664.18190,924-2.44-47.56%
1 Year8.2212.892.666.41260,939-5.53-67.27%
3 Years4.5012.892.667.08215,071-1.81-40.22%
5 Years4.5012.892.667.08215,071-1.81-40.22%

NeuBase Therapeutics Description

NeuBase Therapeutics Inc is a pre-clinical stage bio-pharmaceutical company. It is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platform is focused on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy and Familial Parkinson's Disease among others.


Your Recent History
NASDAQ
NBSE
NeuBase Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.